Thank you for your article. I agree with the potential and vision of Lenzilumab. However, its success elsewhere means little if not shared with us, the loyal shareholders. At this juncture, what is crucial is Cameron's leadership — guiding us, the shareholders, to success. Currently, my primary hope is to see Cameron's leadership in action. Do you have any insights or observations in this regard?
News 
Market Data 
Discover 
AI
